La Cañada Flintridge, CA, United States of America

William H Slattery

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: O-Ray Pharma, Inc.. Active years: 2022.

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of William H. Slattery

Introduction

William H. Slattery is a notable inventor based in La Cañada Flintridge, California, recognized for his contributions to the field of otology. With one patent to his name, Slattery's work focuses on enhancing therapeutic delivery methods, particularly for otic disorders. His innovative ideas have the potential to significantly impact the treatment of hearing-related diseases.

Latest Patents

Slattery's most significant patent is titled "Solid drug implants for intracochlear delivery of therapeutics for the treatment of Otic disorders". This invention presents pharmaceutical preparations, devices, systems, and methods aimed at treating various otic diseases and conditions. His approach enables sustained drug release to address critical issues such as hearing loss, infections, and other pathological conditions affecting the cochlea and inner ear.

Career Highlights

Currently, William H. Slattery is affiliated with O-Ray Pharma, Inc., where he continues to develop innovative solutions for the medical field. His dedication to addressing medical challenges through invention exemplifies his commitment to improving patient outcomes.

Collaborations

Throughout his career, Slattery has collaborated with talented colleagues, including Thomas Smith and Erik Pierstorff. These professional partnerships promote a dynamic exchange of ideas, leading to advancements in their respective fields. Their collective expertise enhances the development of innovative medical solutions.

Conclusion

William H. Slattery's inventive efforts have made a meaningful impact on the treatment of otic disorders. As he continues to work with O-Ray Pharma, Inc. and alongside esteemed colleagues, one can anticipate further advancements that will benefit patients experiencing hearing-related conditions. His work underscores the importance of innovation in improving healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…